Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Type of study
Publication year range
1.
Infect Control Hosp Epidemiol ; 36(11): 1358-60, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26288185

ABSTRACT

We describe a large outbreak associated with a crusted (Norwegian) scabies case in an immunocompromised patient following treatment with TNF-α inhibitor (adalimumab) for psoriasis arthritis. The increasing use of TNF-α inhibitors should induce clinicians to consider this serious parasitic infection when evaluating skin rashes in patients receiving biologic therapies.


Subject(s)
Adalimumab/adverse effects , Cross Infection/epidemiology , Disease Outbreaks , Scabies/epidemiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab/therapeutic use , Aged , Arthritis, Psoriatic/drug therapy , Female , Hospitals , Humans , Immunocompromised Host , Italy
2.
Ig Sanita Pubbl ; 70(6): 635-46, 2014.
Article in Italian | MEDLINE | ID: mdl-25715898

ABSTRACT

In the season 2013-2014, a campaign to promote influenza vaccination among health care workers (HCWs) was conducted in two Italian hospitals, based on an educational toolkit and attitude and compliance towards vaccination were investigated. Overall, 36% of the HCWs get vaccinated almost once, 2.3% in 2013-14 season for the first time, 57% never, 7% do not know or not remember. The main reason for vaccination was reportedly to avoid taking sick-leave (29.7%); while refusal was guided by the low risk-perception associated with influenza (38.5%). Interventions based only on education and communication seem not to be sufficient; an integrated approach with multiple components is needed to achieve higher coverage rates and to ensure a successful vaccination campaign.

SELECTION OF CITATIONS
SEARCH DETAIL